Phlebotek Corporation is categorized under Intermediate Care Facilities in Miami, FL and active since 2011.
Phlebotek Corporation was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Intermediate Care Facilities business, which does work in the B2C market, and is classified as a Intermediate Care Facilities, under code number 623110 by the NAICS.
If you are seeking more information, feel free to contact Phillip Svehla at the company’s single location by writing to 2228 Landmeier Road, Miami, Florida FL 33162 or by phoning (224) 400-6051. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Phlebotek Corporation |
| Contact Person: | Phillip Svehla |
| Address: | 2228 Landmeier Road, Miami, Florida 33162 |
| Phone Number: | (224) 400-6051 |
| Website Address: | phlebotek.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Intermediate Care Facilities |
| SIC Code: | 8052 |
| NAICS Code: | 623110 |
| Share This Business: |
Phlebotek Corporation was started in 2011 to provide professional Intermediate Care Facilities under the SIC code 8052 and NAICS code 623110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Phillip Svehla for inquiries that concern Phlebotek Corporation by calling the company number (224) 400-6051, as your correspondence is most welcome. Additionally, the physical location of the single location of Phlebotek Corporation can be found at the coordinates 42.009615,-87.94786 as well as the street address 2228 Landmeier Road in Miami, Florida 33162.
For its online presence, you may visit Phlebotek Corporation’s website at phlebotek.com and engage with its social media outlets through on Twitter and on Facebook.